Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis

AbstractMultiple sclerosis (MS) commonly affects occupational function. We investigated the link between brain MRI and employment status. Patients with MS (n = 100) completed a Work Productivity and Activity Impairment (WPAI) (general health version) survey measuring employment status, absenteeism, presenteeism, and overall work and daily activity impairment. Patients “working for pay” were considered employed; “temporarily not working but looking for work,” “not working or looking for work due to age,” and “not working or looking for work due to disability” were considered not employed. Brain MRI T1 hypointense (T1LV) and T2 hyperintense (T2LV) lesion volumes were quantified. To assess lesional destructive capability, we calculated each subject’s ratio of T1LV to T2LV (T1/T2). Normalized brain parenchymal volume (BPV) assessed brain atrophy. The mean (SD) age was 45.5 (9.7) years; disease duration was 12.1 (8.1) years; 75 % were women, 76 % were relapsing-remitting, and 76 % were employed. T1LV, T1/T2, Expanded Disability Status Scale (EDSS) scores, and activity impairment were lower and BPV was higher in the employed vs. not employed group (Wilcoxon tests, p < 0.05). Age, disease duration, MS clinical subtype, and T2LV did not differ between groups (p > 0.05). In multivariable logistic regression modeling, adjusting for age, sex, and disease duration, higher T1LV predicted a lower chance of employment (p < 0.05). Pearson correlations showed that EDSS was associated with activity impairment (p < 0.05). Disease duration, age, and MRI measures were not correlated with activity impairment or other WPAI outcomes (p > 0.05). We report a link between brain atrophy and lesions, particularly lesions with destructive potential, to MS employment status.

[1]  P. Arnett,et al.  Factors related to employment status changes in individuals with multiple sclerosis , 2005, Multiple sclerosis.

[2]  M. Schultheis,et al.  Multitasking in multiple sclerosis: can it inform vocational functioning? , 2013, Archives of physical medicine and rehabilitation.

[3]  D. Altmann,et al.  A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis , 2010, Journal of Neurology.

[4]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[5]  Rohit Bakshi,et al.  The Relationships among MRI‐Defined Spinal Cord Involvement, Brain Involvement, and Disability in Multiple Sclerosis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  Ariel Miller,et al.  Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status , 2006, Quality of Life Research.

[7]  M. Battaglia,et al.  Factors that influence the employment status of people with multiple sclerosis: a multi-national study , 2009, Journal of Neurology.

[8]  Susan A Gauthier,et al.  A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. , 2006, Autoimmunity reviews.

[9]  Richard H. Price,et al.  Black Holes , 1997 .

[10]  A. Feinstein,et al.  Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite , 2011, Journal of Neurology.

[11]  Rohit Bakshi,et al.  The measurement and clinical relevance of brain atrophy in multiple sclerosis , 2006, The Lancet Neurology.

[12]  Peter A. Calabresi,et al.  Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis , 2012, PloS one.

[13]  J. DeLuca,et al.  Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing , 2014, Multiple sclerosis.

[14]  H. Weiner,et al.  Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  Rohit Bakshi,et al.  Correlating Brain Atrophy With Cognitive Dysfunction, Mood Disturbances, and Personality Disorder in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[16]  O. Ciccarelli,et al.  Brain atrophy and lesion load predict long term disability in multiple sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  T. Pickersgill,et al.  Demographic and clinical factors associated with changes in employment in multiple sclerosis , 2013, Multiple sclerosis.

[18]  R. Benedict,et al.  Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline , 2010, The Clinical neuropsychologist.

[19]  Rohit Bakshi,et al.  Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. , 2008, Archives of neurology.

[20]  V. Janardhan,et al.  Brain MRI lesions and atrophy are related to depression in multiple sclerosis , 2000, Neuroreport.

[21]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[22]  M. Leonardi,et al.  Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002–2011 literature , 2013, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[23]  Kesshi M Jordan,et al.  Spinal cord gray matter atrophy correlates with multiple sclerosis disability , 2014, Annals of neurology.

[24]  R. Benedict,et al.  Unemployment in multiple sclerosis: the contribution of personality and disease , 2012, Multiple sclerosis.

[25]  P. Narayana,et al.  Is 3D MPRAGE better than the combination DIR/PSIR for cortical lesion detection at 3T MRI? , 2014, Multiple sclerosis and related disorders.

[26]  H. Schild,et al.  High field MR imaging and 1H-MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 2007, Journal of Neurology.

[27]  P. Narayana,et al.  Composite MRI scores improve correlation with EDSS in multiple sclerosis , 2010, Multiple sclerosis.

[28]  D. Ramasamy,et al.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome , 2014, Journal of Neurology.

[29]  Massimo Filippi,et al.  Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink? , 2014, Current opinion in neurology.

[30]  J. Aarseth,et al.  Employment among Patients with Multiple Sclerosis-A Population Study , 2014, PloS one.

[31]  Hsiao-Fang Liang,et al.  Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords , 2011, NeuroImage.

[32]  C. Pfueller,et al.  Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. , 2012, Archives of neurology.

[33]  Rohit Bakshi,et al.  Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[34]  J. Ranjeva,et al.  Sodium imaging as a marker of tissue injury in patients with multiple sclerosis. , 2013, Multiple sclerosis and related disorders.

[35]  J. Sumowski,et al.  Cognitive reserve in multiple sclerosis , 2013, Multiple sclerosis.

[36]  C. Tench,et al.  Measurement of Spinal Cord Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[37]  Yonggang Shi,et al.  Detection of altered hippocampal morphology in multiple sclerosis‐associated depression using automated surface mesh modeling , 2014, Human brain mapping.

[38]  Ludwig Kappos,et al.  Label‐fusion‐segmentation and deformation‐based shape analysis of deep gray matter in multiple sclerosis: The impact of thalamic subnuclei on disability , 2014, Human brain mapping.

[39]  T. Ziemssen,et al.  Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors , 2013, Multiple sclerosis.

[40]  C. Guttmann,et al.  An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2 , 2014, Neuroreport.

[41]  Nick C. Fox,et al.  Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.

[42]  O. Ciccarelli,et al.  Spinal cord repair in MS , 2010, Neurology.

[43]  Massimo Filippi,et al.  Association between pathological and MRI findings in multiple sclerosis , 2012, The Lancet Neurology.

[44]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[45]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[46]  T. Benner,et al.  Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH‐T2* , 2012, Journal of magnetic resonance imaging : JMRI.

[47]  C. Guttmann,et al.  Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study , 2012, Journal of the Neurological Sciences.